• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌筛查中的自我采样:基于刷子和基于灌洗的宫颈阴道自我采样装置的比较

Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device.

作者信息

Karjalainen Liisa, Anttila Ahti, Nieminen Pekka, Luostarinen Tapio, Virtanen Anni

机构信息

Mass Screening Registry, Finnish Cancer Registry, Unioninkatu 22, FI-00130, Helsinki, Finland.

Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, Jorvi Hospital, Turuntie 150, Espoo, Finland.

出版信息

BMC Cancer. 2016 Mar 15;16:221. doi: 10.1186/s12885-016-2246-9.

DOI:10.1186/s12885-016-2246-9
PMID:26979237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4791879/
Abstract

BACKGROUND

High coverage and attendance is essential for cervical cancer screening success. We investigated whether the previous positive experiences on increasing screening attendance by self-sampling in Finland are sampler device dependent.

METHODS

All women identified to cervical cancer screening in 2013 in 28 Finnish municipalities were randomised to receive a lavage- (n = 6030) or a brush type of self-sampling device (n = 6045) in case of non-attendance after two invitation letters. Seven hundred seventy non-attending women in the lavage device group and 734 in the brush group received the self-sampling offer. Women's experiences were enquired with an enclosed questionnaire.

RESULTS

Total attendance in the lavage group increased from 71.0 to 77.7% by reminder letters and further to 80.5% by self-sampling. Respective increase in the brush group was from 72.2 to 78.6% and then to 81.5%. The participation by self-sampling was 21.7% (95% CI 18.8-24.6) in the lavage group and 23.8% (95% CI 20.8-26.9) in the brush group. Women's self-sampling experiences were mainly positive and the sampler devices were equally well accepted by the women.

CONCLUSION

Our study shows that the lavage device and brush device perform similarly in terms of uptake by non-attending women and user comfort. If self-sampling is integrated to the routine screening program in Finland, either of the devices can be chosen without the fear of losing participants due to a less acceptable device.

摘要

背景

高覆盖率和高参与率是宫颈癌筛查成功的关键。我们调查了芬兰以往通过自我采样提高筛查参与率的积极经验是否依赖于采样设备。

方法

2013年在芬兰28个城市被确定需进行宫颈癌筛查的所有女性,在收到两封邀请信后仍未参加筛查的情况下,被随机分配接受灌洗式采样设备(n = 6030)或刷式自我采样设备(n = 6045)。灌洗式采样设备组的770名未参加筛查的女性和刷式采样设备组的734名未参加筛查的女性收到了自我采样邀请。通过随附的问卷询问女性的体验。

结果

灌洗式采样设备组通过提醒信,总参与率从71.0%提高到77.7%,通过自我采样进一步提高到80.5%。刷式采样设备组的相应提高分别为从72.2%到78.6%,然后到81.5%。灌洗式采样设备组自我采样的参与率为21.7%(95%置信区间18.8 - 24.6),刷式采样设备组为23.8%(95%置信区间20.8 - 26.9)。女性的自我采样体验主要是积极的,两种采样设备被女性接受的程度相同。

结论

我们的研究表明,灌洗式采样设备和刷式采样设备在未参加筛查女性的接受度和用户舒适度方面表现相似。如果将自我采样纳入芬兰的常规筛查计划,可以选择任何一种设备,不用担心因设备接受度较低而导致参与者流失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d464/4791879/d7094143ae58/12885_2016_2246_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d464/4791879/3401401e6c30/12885_2016_2246_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d464/4791879/434a1d48c807/12885_2016_2246_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d464/4791879/d7094143ae58/12885_2016_2246_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d464/4791879/3401401e6c30/12885_2016_2246_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d464/4791879/434a1d48c807/12885_2016_2246_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d464/4791879/d7094143ae58/12885_2016_2246_Fig3_HTML.jpg

相似文献

1
Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device.宫颈癌筛查中的自我采样:基于刷子和基于灌洗的宫颈阴道自我采样装置的比较
BMC Cancer. 2016 Mar 15;16:221. doi: 10.1186/s12885-016-2246-9.
2
Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening.30130名未参加宫颈筛查女性中新型自我采样方法检测高危型人乳头瘤病毒的比较性能
Int J Cancer. 2015 Feb 1;136(3):646-55. doi: 10.1002/ijc.29026. Epub 2014 Jun 26.
3
Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.通过自行采集宫颈阴道灌洗液进行高危型人乳头瘤病毒(HPV)的初筛,是未接受筛查女性的一种替代筛查工具。
J Clin Pathol. 2002 Jun;55(6):435-9. doi: 10.1136/jcp.55.6.435.
4
The acceptability of a self-lavaging device compared to pelvic examination for cervical cancer screening among low-income women.一种自我清洗装置在低收入妇女宫颈癌筛查中相较于盆腔检查的可接受性。
J Womens Health (Larchmt). 2012 Dec;21(12):1275-81. doi: 10.1089/jwh.2012.3512. Epub 2012 Aug 20.
5
Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.CHOiCE试验方案:一项针对未参加有组织宫颈癌筛查项目者的基于家庭的HPV自我采样的三臂随机对照试验。
BMC Cancer. 2016 Nov 3;16(1):835. doi: 10.1186/s12885-016-2859-z.
6
Self-sampling experiences among non-attendees to cervical screening.未参加宫颈癌筛查人群的自我采样体验。
Gynecol Oncol. 2014 Dec;135(3):487-94. doi: 10.1016/j.ygyno.2014.09.019. Epub 2014 Oct 2.
7
Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN.毛刷取样联合 GP5+/6+-PCR 检测人乳头瘤病毒:与医师采集的宫颈刮片相比,在 HPV 基因分型和检测高级别宫颈上皮内瘤变方面具有高度一致性。
J Clin Virol. 2012 Jun;54(2):147-51. doi: 10.1016/j.jcv.2012.02.022. Epub 2012 Mar 23.
8
[Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].[宫颈癌筛查中使用人乳头瘤病毒检测自采样试剂盒的初步研究]
Ceska Gynekol. 2015 Dec;80(6):436-43.
9
Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.高危型人乳头瘤病毒检测在未参加宫颈癌筛查项目的阴道刷自采样中的应用经验。
Int J Cancer. 2012 Mar 1;130(5):1128-35. doi: 10.1002/ijc.26128. Epub 2011 May 30.
10
HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.HPV 检测在自行收集的宫颈阴道灌洗液标本中的应用作为未参加宫颈癌筛查女性的筛查方法:队列研究。
BMJ. 2010 Mar 11;340:c1040. doi: 10.1136/bmj.c1040.

引用本文的文献

1
A Comprehensive Review of Cervical Cancer Screening Devices: The Pros and the Cons.宫颈癌筛查设备的全面综述:优缺点。
Asian Pac J Cancer Prev. 2023 Jul 1;24(7):2207-2215. doi: 10.31557/APJCP.2023.24.7.2207.
2
Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.日本宫颈癌筛查中人乳头瘤病毒自我采样检测的可接受性:ACCESS 试验中的问卷调查。
PLoS One. 2023 Jun 8;18(6):e0286909. doi: 10.1371/journal.pone.0286909. eCollection 2023.
3
Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.

本文引用的文献

1
Self-sampling experiences among non-attendees to cervical screening.未参加宫颈癌筛查人群的自我采样体验。
Gynecol Oncol. 2014 Dec;135(3):487-94. doi: 10.1016/j.ygyno.2014.09.019. Epub 2014 Oct 2.
2
Improving cervical cancer screening attendance in Finland.提高芬兰宫颈癌筛查参与率。
Int J Cancer. 2015 Mar 15;136(6):E677-84. doi: 10.1002/ijc.29176. Epub 2014 Sep 15.
3
Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening.
自我采样用于人乳头瘤病毒检测是否有可能增加宫颈癌筛查?观察性研究和随机临床试验的更新荟萃分析。
Front Public Health. 2022 Dec 8;10:1003461. doi: 10.3389/fpubh.2022.1003461. eCollection 2022.
4
Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly.向所有符合宫颈癌筛查条件的女性广泛提供人乳头瘤病毒自我采样服务:欲速则不达。
Int J Cancer. 2023 Jul 1;153(1):8-19. doi: 10.1002/ijc.34358. Epub 2022 Nov 23.
5
Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial.在日本,针对宫颈癌筛查无应答者实施自我采样 HPV 检测的实施情况:ACCESS 试验的二次分析。
Sci Rep. 2022 Aug 25;12(1):14531. doi: 10.1038/s41598-022-18800-w.
6
Human papillomavirus self-sampling with mRNA testing benefits routine screening.人乳头瘤病毒 mRNA 检测的自我采样有益于常规筛查。
Int J Cancer. 2022 Dec 1;151(11):1989-1996. doi: 10.1002/ijc.34170. Epub 2022 Jun 28.
7
Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer.大流行后宫颈癌筛查:加速消除宫颈癌的自我采样机会
Int J Womens Health. 2021 Sep 18;13:841-859. doi: 10.2147/IJWH.S288376. eCollection 2021.
8
Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials.撒哈拉以南非洲地区宫颈癌筛查中人类乳头瘤病毒自我采样与标准临床医生采样的比较:一项随机对照试验的系统评价和荟萃分析
Infect Agent Cancer. 2021 Jun 19;16(1):43. doi: 10.1186/s13027-021-00380-5.
9
Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.三种不同宫颈癌筛查方式的满意度评估:临床医生采集的巴氏涂片检测与自我采样 HPV 检测和尿液采样 HPV 检测的比较。
J Gynecol Oncol. 2019 Sep;30(5):e76. doi: 10.3802/jgo.2019.30.e76.
10
Acceptability of Human Papillomavirus Self-Sampling Among a National Sample of Women in the United States.人乳头瘤病毒自我采样在美国全国女性样本中的可接受性。
Biores Open Access. 2019 Apr 30;8(1):65-73. doi: 10.1089/biores.2018.0040. eCollection 2019.
30130名未参加宫颈筛查女性中新型自我采样方法检测高危型人乳头瘤病毒的比较性能
Int J Cancer. 2015 Feb 1;136(3):646-55. doi: 10.1002/ijc.29026. Epub 2014 Jun 26.
4
Cervical cancer screening: on the way to a shift from cytology to full molecular screening.宫颈癌筛查:从细胞学筛查向全分子筛查转变的路上。
Ann Oncol. 2014 May;25(5):927-35. doi: 10.1093/annonc/mdt538. Epub 2014 Jan 19.
5
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.人乳头瘤病毒自我采集与临床医生采集样本检测的准确性:荟萃分析。
Lancet Oncol. 2014 Feb;15(2):172-83. doi: 10.1016/S1470-2045(13)70570-9. Epub 2014 Jan 14.
6
Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.芬兰组织性和机会性巴氏涂片检查的覆盖范围、频率和费用存在差异。
Int J Cancer. 2014 Jul 1;135(1):204-13. doi: 10.1002/ijc.28646. Epub 2013 Dec 18.
7
Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.在芬兰接受宫颈癌筛查的女性中,人乳头瘤病毒的类型和年龄特异性分布。
Br J Cancer. 2013 Nov 26;109(11):2941-50. doi: 10.1038/bjc.2013.647. Epub 2013 Oct 17.
8
Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.增加宫颈癌筛查参与率:在 RACOMIP(一项瑞典随机对照试验)中,为长期未参与者提供 HPV 自我检测。
Int J Cancer. 2014 May 1;134(9):2223-30. doi: 10.1002/ijc.28545. Epub 2013 Oct 31.
9
HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.HPV 自我采样或巴氏涂片检查:法国社会经济地位较低的宫颈癌筛查未参与者中一项随机研究。
Int J Cancer. 2013 Dec 1;133(11):2681-7. doi: 10.1002/ijc.28283. Epub 2013 Jul 23.
10
Mortality audit of the Finnish cervical cancer screening program.芬兰宫颈癌筛查项目的死亡率审核。
Int J Cancer. 2013 May 1;132(9):2134-40. doi: 10.1002/ijc.27844. Epub 2012 Oct 12.